Science
Scientifically inspired,
naturally perfected.
Biomimetic membrane systems
Investigation of cellular lipid structures for the optimization of dermal barrier function through biomimetic reconstruction.
Epidermal Growth Factors and LNP Encapsulation
Stabilization of growth factors in lipid nanoparticles for controlled release in deeper skin layers.
Preservative-free Formulations
Development of self-preserving systems using biomimetic active ingredients without traditional preservatives.
Nobel Prize context of
EGF research
The discovery of Epidermal Growth Factor (EGF) marks a milestone in modern cell biology. In 1986, Stanley Cohen and Rita Levi-Montalcini received the Nobel Prize in Physiology or Medicine for their isolation and characterization of EGF. This research laid the foundation for understanding how cells control growth and differentiation. In biomimetic skincare, we use these insights to specifically support the skin's own regeneration and to perfect the barrier function at a molecular level.
Research & Development Pipeline
In development
Stabilized LNP-EGF complexes
Optimization of lipid nanoparticle encapsulation for temperature-stable release of epidermal growth factor in topical formulations.
Status: In Vitro Validation
In development
Biomimetic Barrier Matrix v2.0
Further development of the lamellar DermaMimetic® structure for the integration of hydrophilic active ingredients without loss of membrane integrity.
Status: Prototyping
In development
Preservative-free hyaluronic complexes
Research on microbiologically stable formulations through pH control and anhydrous lipid phase configuration.
Status: Feasibility study
In development
Neuro-biomimetic adjuvants
Investigation of peptide chains for the modulation of skin receptor response in hypersensitive, biomimetically treated skin.
Status: Early Stage R&D